Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients

(2012) Jay S. Schneider et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial

(2012) T. Coelho et al.   NEUROLOGY

Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade

(2012) C. E. Bulawa et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Familial amyloid polyneuropathy

(2009) Gérard Said et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival

(2009) Sadahisa Okamoto et al.   LIVER TRANSPLANTATION

The Delayed-Start Study Design

(2009) Ralph B. D'Agostino   NEW ENGLAND JOURNAL OF MEDICINE

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses

(2008) Yoshiki Sekijima et al.   CURRENT PHARMACEUTICAL DESIGN

A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics

(2008) C. Warren Olanow et al.   MOVEMENT DISORDERS